Chapter 45

Small Solute Clearance in Peritoneal Dialysis

Kannaiyan S. Rabindranath

Kannaiyan S. Rabindranath

Renal Unit, Waikato Hospital, Hamilton, New Zealand

Search for more papers by this author
Sharon J. Nessim

Sharon J. Nessim

Division of Nephrology, Jewish General Hospital, McGill University, Montreal, Canada

Search for more papers by this author
Joanne M. Bargman

Joanne M. Bargman

Department of Medicine, Division of Nephrology, University of Toronto, Toronto, Canada

Search for more papers by this author
First published: 18 November 2022

Summary

The ideal method of assessing the adequacy of peritoneal dialysis (PD) has yet to be determined. While measures of solute clearance have traditionally focused on small solutes such as urea and creatinine, little attention has been paid to clearance of larger molecular weight uremic toxins, the so-called “middle molecules” and protein-bound uremic toxins which may have important pathophysiological impacts on mortality and morbidity. The peritoneum is a serous semipermeable membrane composed of a thin layer of connective tissue covered by a mesothelial cell monolayer. The peritoneal equilibration test is the most widely used test to characterize the rate of solute and water transfer in patients undergoing PD. The routine measurement of small solute clearance serves to screen patients for evidence of underdialysis. Aminoglycosides are frequently used to treat peritonitis in PD patients because of their effectiveness as bactericidal agents and the ease of intraperitoneal administration.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.